Department of Obstetrics and Gynecology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Sci Rep. 2021 Jan 15;11(1):1584. doi: 10.1038/s41598-020-80598-2.
The study aims to evaluate the effectiveness of local injection of autologous platelet rich plasma (A-PRP) as a treatment for women suffering from stress urinary incontinence (SUI). In a prospective intervention study, twenty consecutive women suffering from SUI were treated with A-PRP injection at anterior vaginal wall where mid-urethra locates. Self-reported questionnaires were used to measure pre-treatment, 1 month and 6 months post-treatment symptom severity. Secondary outcomes of sexual function and treatment effect sorted by age were analyzed with valid statistical methods. A-PRP is effective in relieving SUI symptoms at both 1 month and 6 months post-treatment without significant adverse reactions reported. It seems to have a trend that treatment success rate with cured and improved symptoms was slightly higher in the younger group, although it did not reach statistical significance (P = 0.07). No significant changes in sexual function before and after the treatment were reported by the patients. This pilot study is the first to report A-PRP treatment effect for SUI in women. The result suggested that A-PRP is a considerable treatment option for mild to moderate SUI cases. It also opens up further research opportunities for A-PRP's clinical applications.
本研究旨在评估局部注射自体富血小板血浆(A-PRP)治疗女性压力性尿失禁(SUI)的疗效。在一项前瞻性干预研究中,连续 20 名患有 SUI 的女性在前阴道壁(中尿道位置)接受 A-PRP 注射治疗。采用自我报告问卷在治疗前、治疗后 1 个月和 6 个月测量症状严重程度。采用有效统计方法分析按年龄分层的性功能和治疗效果的次要结局。A-PRP 在治疗后 1 个月和 6 个月均能有效缓解 SUI 症状,且无明显不良反应。尽管未达到统计学意义(P=0.07),但似乎在年轻组中治愈和改善症状的治疗成功率略高。患者在治疗前后的性功能无明显变化。本初步研究首次报道了 A-PRP 治疗女性 SUI 的疗效。结果表明,A-PRP 是治疗轻中度 SUI 的一种有价值的选择。它也为 A-PRP 的临床应用开辟了进一步的研究机会。